SCHEMBL1923810

SCHEMBL1923810

O=C(O)C1CCCN1C(=O)CI

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 10/20 0.62
▸ MVD P53602 2/20 0.51
▸ REN P00797 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ F2 P00734 1/20 0.50
▸ LTA4H P09960 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ PEPD P12955 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ HRH1 P35367 1/20 0.50
▸ THPO P40225 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ ACE2 Q9BYF1 1/20 0.50
▸ RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22224221 0.94 ACE (0.56) ACEMVDRENLMNAHSD17B10
SCHEMBL1362022 0.86 ACE (0.64) ACEMVDRENLMNAHSD17B10
SCHEMBL6782705 0.84 ACE (0.72) ACEMVDREN
SCHEMBL6782701 0.84 ACE (0.72) ACEMVDREN
SCHEMBL19710618 0.83 DPP4 (0.46) ACE
SCHEMBL5633664 0.82 ACE (0.64) ACEMVDRENLMNAHSD17B10
SCHEMBL1537428 0.82 ACE (0.64) ACEMVDRENLMNAHSD17B10
SCHEMBL19037813 0.82 ACE (0.64) ACEMVDRENLMNAHSD17B10
SCHEMBL18894243 0.81 ACE (0.62) ACEMVDRENLMNAHSD17B10
Glycyl Proline SCHEMBL155067 0.81 ACE (0.62) ACEMVDRENLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993554-A2 UROTENSIN II RECEPTOR ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2008-11-26 — — EP claimed
WO-2007081995-A2 UROTENSIN II RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-19 — — WO claimed
EP-2212282-B1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2011-09-21 — — EP disclosed
EP-2328865-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-08 — — EP disclosed
WO-2010039793-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-08 — — WO disclosed
Send feedback